BARDA awards Cytori up to $106M

Cytori Therapeutics Inc. (NASDAQ:CYTX; Xetra:XMPA) gained $0.55 (14%) to $4.41 on Friday after HHS's Biomedical Advanced Research and Development Authority (BARDA) awarded the company a contract worth up to $106 million to develop a cell therapy to treat thermal burns from radiation injury. The product comprises a patient's own adipose-derived stem and regenerative cells (ADRCs) processed by Cytori's Celution System. ...